0000830656
false
--12-31
2021
Q3
6
2.50
2.50
2.50
2.50
7
3.00
8
8
8
9
7
7
7
7
7
7
P5Y
P1M
P5Y
P5Y
P5Y
P30Y
P3Y
P10Y
P7Y11M15D
P5Y
P3Y
P5Y
P5Y
P3Y
P5Y
P5Y
P0Y12M0D
100000
23000
0000830656
2021-01-01
2021-09-30
0000830656
2021-11-10
0000830656
2021-09-30
0000830656
2020-12-31
0000830656
PBIO:SeriesDConvertiblePreferredStockMember
2020-12-31
0000830656
PBIO:SeriesDConvertiblePreferredStockMember
2021-09-30
0000830656
PBIO:SeriesGConvertiblePreferredStockMember
2020-12-31
0000830656
PBIO:SeriesGConvertiblePreferredStockMember
2021-09-30
0000830656
PBIO:SeriesHConvertiblePreferredStockMember
2020-12-31
0000830656
PBIO:SeriesHConvertiblePreferredStockMember
2021-09-30
0000830656
PBIO:SeriesH2ConvertiblePreferredStockMember
2020-12-31
0000830656
PBIO:SeriesH2ConvertiblePreferredStockMember
2021-09-30
0000830656
PBIO:SeriesJConvertiblePreferredStockMember
2020-12-31
0000830656
PBIO:SeriesJConvertiblePreferredStockMember
2021-09-30
0000830656
PBIO:SeriesKConvertiblePreferredStockMember
2020-12-31
0000830656
PBIO:SeriesKConvertiblePreferredStockMember
2021-09-30
0000830656
PBIO:SeriesAAConvertiblePreferredStockMember
2020-12-31
0000830656
PBIO:SeriesAAConvertiblePreferredStockMember
2021-09-30
0000830656
2021-07-01
2021-09-30
0000830656
2020-07-01
2020-09-30
0000830656
2020-01-01
2020-09-30
0000830656
PBIO:ProductsServicesOtherMember
2021-07-01
2021-09-30
0000830656
PBIO:ProductsServicesOtherMember
2020-07-01
2020-09-30
0000830656
PBIO:ProductsServicesOtherMember
2021-01-01
2021-09-30
0000830656
PBIO:ProductsServicesOtherMember
2020-01-01
2020-09-30
0000830656
2019-12-31
0000830656
2020-09-30
0000830656
PBIO:SerisDPreferredStockMember
2019-12-31
0000830656
PBIO:SerisGPreferredStockMember
2019-12-31
0000830656
PBIO:SerisHPreferredStockMember
2019-12-31
0000830656
PBIO:SerisHTwoPreferredStockMember
2019-12-31
0000830656
PBIO:SerisJPreferredStockMember
2019-12-31
0000830656
PBIO:SerisKPreferredStockMember
2019-12-31
0000830656
PBIO:SerisAAPreferredStockMember
2019-12-31
0000830656
us-gaap:CommonStockMember
2019-12-31
0000830656
PBIO:StockWarrantsMember
2019-12-31
0000830656
us-gaap:AdditionalPaidInCapitalMember
2019-12-31
0000830656
us-gaap:RetainedEarningsMember
2019-12-31
0000830656
PBIO:SerisDPreferredStockMember
2020-01-01
2020-03-31
0000830656
PBIO:SerisGPreferredStockMember
2020-01-01
2020-03-31
0000830656
PBIO:SerisHPreferredStockMember
2020-01-01
2020-03-31
0000830656
PBIO:SerisHTwoPreferredStockMember
2020-01-01
2020-03-31
0000830656
PBIO:SerisJPreferredStockMember
2020-01-01
2020-03-31
0000830656
PBIO:SerisKPreferredStockMember
2020-01-01
2020-03-31
0000830656
PBIO:SerisAAPreferredStockMember
2020-01-01
2020-03-31
0000830656
us-gaap:CommonStockMember
2020-01-01
2020-03-31
0000830656
PBIO:StockWarrantsMember
2020-01-01
2020-03-31
0000830656
us-gaap:AdditionalPaidInCapitalMember
2020-01-01
2020-03-31
0000830656
us-gaap:RetainedEarningsMember
2020-01-01
2020-03-31
0000830656
2020-01-01
2020-03-31
0000830656
PBIO:SerisDPreferredStockMember
2021-01-01
2021-03-31
0000830656
PBIO:SerisDPreferredStockMember
2020-03-31
0000830656
PBIO:SerisGPreferredStockMember
2020-03-31
0000830656
PBIO:SerisHPreferredStockMember
2020-03-31
0000830656
PBIO:SerisHTwoPreferredStockMember
2020-03-31
0000830656
PBIO:SerisJPreferredStockMember
2020-03-31
0000830656
PBIO:SerisKPreferredStockMember
2020-03-31
0000830656
PBIO:SerisAAPreferredStockMember
2020-03-31
0000830656
us-gaap:CommonStockMember
2020-03-31
0000830656
PBIO:StockWarrantsMember
2020-03-31
0000830656
us-gaap:AdditionalPaidInCapitalMember
2020-03-31
0000830656
us-gaap:RetainedEarningsMember
2020-03-31
0000830656
2020-03-31
0000830656
PBIO:SerisDPreferredStockMember
2020-04-01
2020-06-30
0000830656
PBIO:SerisGPreferredStockMember
2020-04-01
2020-06-30
0000830656
PBIO:SerisHPreferredStockMember
2020-04-01
2020-06-30
0000830656
PBIO:SerisHTwoPreferredStockMember
2020-04-01
2020-06-30
0000830656
PBIO:SerisJPreferredStockMember
2020-04-01
2020-06-30
0000830656
PBIO:SerisKPreferredStockMember
2020-04-01
2020-06-30
0000830656
PBIO:SerisAAPreferredStockMember
2020-04-01
2020-06-30
0000830656
us-gaap:CommonStockMember
2020-04-01
2020-06-30
0000830656
PBIO:StockWarrantsMember
2020-04-01
2020-06-30
0000830656
us-gaap:AdditionalPaidInCapitalMember
2020-04-01
2020-06-30
0000830656
us-gaap:RetainedEarningsMember
2020-04-01
2020-06-30
0000830656
2020-04-01
2020-06-30
0000830656
PBIO:SerisDPreferredStockMember
2020-06-30
0000830656
PBIO:SerisGPreferredStockMember
2020-06-30
0000830656
PBIO:SerisHPreferredStockMember
2020-06-30
0000830656
PBIO:SerisHTwoPreferredStockMember
2020-06-30
0000830656
PBIO:SerisJPreferredStockMember
2020-06-30
0000830656
PBIO:SerisKPreferredStockMember
2020-06-30
0000830656
PBIO:SerisAAPreferredStockMember
2020-06-30
0000830656
us-gaap:CommonStockMember
2020-06-30
0000830656
PBIO:StockWarrantsMember
2020-06-30
0000830656
us-gaap:AdditionalPaidInCapitalMember
2020-06-30
0000830656
us-gaap:RetainedEarningsMember
2020-06-30
0000830656
2020-06-30
0000830656
PBIO:SerisDPreferredStockMember
2020-07-01
2020-09-30
0000830656
PBIO:SerisGPreferredStockMember
2020-07-01
2020-09-30
0000830656
PBIO:SerisHPreferredStockMember
2020-07-01
2020-09-30
0000830656
PBIO:SerisHTwoPreferredStockMember
2020-07-01
2020-09-30
0000830656
PBIO:SerisJPreferredStockMember
2020-07-01
2020-09-30
0000830656
PBIO:SerisKPreferredStockMember
2020-07-01
2020-09-30
0000830656
PBIO:SerisAAPreferredStockMember
2020-07-01
2020-09-30
0000830656
us-gaap:CommonStockMember
2020-07-01
2020-09-30
0000830656
PBIO:StockWarrantsMember
2020-07-01
2020-09-30
0000830656
us-gaap:AdditionalPaidInCapitalMember
2020-07-01
2020-09-30
0000830656
us-gaap:RetainedEarningsMember
2020-07-01
2020-09-30
0000830656
PBIO:SerisDPreferredStockMember
2020-09-30
0000830656
PBIO:SerisGPreferredStockMember
2020-09-30
0000830656
PBIO:SerisHPreferredStockMember
2020-09-30
0000830656
PBIO:SerisHTwoPreferredStockMember
2020-09-30
0000830656
PBIO:SerisJPreferredStockMember
2020-09-30
0000830656
PBIO:SerisKPreferredStockMember
2020-09-30
0000830656
PBIO:SerisAAPreferredStockMember
2020-09-30
0000830656
us-gaap:CommonStockMember
2020-09-30
0000830656
PBIO:StockWarrantsMember
2020-09-30
0000830656
us-gaap:AdditionalPaidInCapitalMember
2020-09-30
0000830656
us-gaap:RetainedEarningsMember
2020-09-30
0000830656
PBIO:SerisDPreferredStockMember
2020-12-31
0000830656
PBIO:SerisGPreferredStockMember
2020-12-31
0000830656
PBIO:SerisHPreferredStockMember
2020-12-31
0000830656
PBIO:SerisHTwoPreferredStockMember
2020-12-31
0000830656
PBIO:SerisJPreferredStockMember
2020-12-31
0000830656
PBIO:SerisKPreferredStockMember
2020-12-31
0000830656
PBIO:SerisAAPreferredStockMember
2020-12-31
0000830656
us-gaap:CommonStockMember
2020-12-31
0000830656
PBIO:StockWarrantsMember
2020-12-31
0000830656
us-gaap:AdditionalPaidInCapitalMember
2020-12-31
0000830656
us-gaap:RetainedEarningsMember
2020-12-31
0000830656
PBIO:SerisGPreferredStockMember
2021-01-01
2021-03-31
0000830656
PBIO:SerisHPreferredStockMember
2021-01-01
2021-03-31
0000830656
PBIO:SerisHTwoPreferredStockMember
2021-01-01
2021-03-31
0000830656
PBIO:SerisJPreferredStockMember
2021-01-01
2021-03-31
0000830656
PBIO:SerisKPreferredStockMember
2021-01-01
2021-03-31
0000830656
PBIO:SerisAAPreferredStockMember
2021-01-01
2021-03-31
0000830656
us-gaap:CommonStockMember
2021-01-01
2021-03-31
0000830656
PBIO:StockWarrantsMember
2021-01-01
2021-03-31
0000830656
us-gaap:AdditionalPaidInCapitalMember
2021-01-01
2021-03-31
0000830656
us-gaap:RetainedEarningsMember
2021-01-01
2021-03-31
0000830656
2021-01-01
2021-03-31
0000830656
PBIO:SerisDPreferredStockMember
2021-03-31
0000830656
PBIO:SerisGPreferredStockMember
2021-03-31
0000830656
PBIO:SerisHPreferredStockMember
2021-03-31
0000830656
PBIO:SerisHTwoPreferredStockMember
2021-03-31
0000830656
PBIO:SerisJPreferredStockMember
2021-03-31
0000830656
PBIO:SerisKPreferredStockMember
2021-03-31
0000830656
PBIO:SerisAAPreferredStockMember
2021-03-31
0000830656
us-gaap:CommonStockMember
2021-03-31
0000830656
PBIO:StockWarrantsMember
2021-03-31
0000830656
us-gaap:AdditionalPaidInCapitalMember
2021-03-31
0000830656
us-gaap:RetainedEarningsMember
2021-03-31
0000830656
2021-03-31
0000830656
PBIO:SerisDPreferredStockMember
2021-04-01
2021-06-30
0000830656
PBIO:SerisGPreferredStockMember
2021-04-01
2021-06-30
0000830656
PBIO:SerisHPreferredStockMember
2021-04-01
2021-06-30
0000830656
PBIO:SerisHTwoPreferredStockMember
2021-04-01
2021-06-30
0000830656
PBIO:SerisJPreferredStockMember
2021-04-01
2021-06-30
0000830656
PBIO:SerisKPreferredStockMember
2021-04-01
2021-06-30
0000830656
PBIO:SerisAAPreferredStockMember
2021-04-01
2021-06-30
0000830656
us-gaap:CommonStockMember
2021-04-01
2021-06-30
0000830656
PBIO:StockWarrantsMember
2021-04-01
2021-06-30
0000830656
us-gaap:AdditionalPaidInCapitalMember
2021-04-01
2021-06-30
0000830656
us-gaap:RetainedEarningsMember
2021-04-01
2021-06-30
0000830656
2021-04-01
2021-06-30
0000830656
PBIO:SerisDPreferredStockMember
2021-06-30
0000830656
PBIO:SerisGPreferredStockMember
2021-06-30
0000830656
PBIO:SerisHPreferredStockMember
2021-06-30
0000830656
PBIO:SerisHTwoPreferredStockMember
2021-06-30
0000830656
PBIO:SerisJPreferredStockMember
2021-06-30
0000830656
PBIO:SerisKPreferredStockMember
2021-06-30
0000830656
PBIO:SerisAAPreferredStockMember
2021-06-30
0000830656
us-gaap:CommonStockMember
2021-06-30
0000830656
PBIO:StockWarrantsMember
2021-06-30
0000830656
us-gaap:AdditionalPaidInCapitalMember
2021-06-30
0000830656
us-gaap:RetainedEarningsMember
2021-06-30
0000830656
2021-06-30
0000830656
PBIO:SerisDPreferredStockMember
2021-07-01
2021-09-30
0000830656
PBIO:SerisGPreferredStockMember
2021-07-01
2021-09-30
0000830656
PBIO:SerisHPreferredStockMember
2021-07-01
2021-09-30
0000830656
PBIO:SerisHTwoPreferredStockMember
2021-07-01
2021-09-30
0000830656
PBIO:SerisJPreferredStockMember
2021-07-01
2021-09-30
0000830656
PBIO:SerisKPreferredStockMember
2021-07-01
2021-09-30
0000830656
PBIO:SerisAAPreferredStockMember
2021-07-01
2021-09-30
0000830656
us-gaap:CommonStockMember
2021-07-01
2021-09-30
0000830656
PBIO:StockWarrantsMember
2021-07-01
2021-09-30
0000830656
us-gaap:AdditionalPaidInCapitalMember
2021-07-01
2021-09-30
0000830656
us-gaap:RetainedEarningsMember
2021-07-01
2021-09-30
0000830656
PBIO:SerisDPreferredStockMember
2021-09-30
0000830656
PBIO:SerisGPreferredStockMember
2021-09-30
0000830656
PBIO:SerisHPreferredStockMember
2021-09-30
0000830656
PBIO:SerisHTwoPreferredStockMember
2021-09-30
0000830656
PBIO:SerisJPreferredStockMember
2021-09-30
0000830656
PBIO:SerisKPreferredStockMember
2021-09-30
0000830656
PBIO:SerisAAPreferredStockMember
2021-09-30
0000830656
us-gaap:CommonStockMember
2021-09-30
0000830656
PBIO:StockWarrantsMember
2021-09-30
0000830656
us-gaap:AdditionalPaidInCapitalMember
2021-09-30
0000830656
us-gaap:RetainedEarningsMember
2021-09-30
0000830656
srt:NorthAmericaMember
2021-07-01
2021-09-30
0000830656
srt:NorthAmericaMember
2020-07-01
2020-09-30
0000830656
srt:NorthAmericaMember
2021-01-01
2021-09-30
0000830656
srt:NorthAmericaMember
2020-01-01
2020-09-30
0000830656
srt:EuropeMember
2021-07-01
2021-09-30
0000830656
srt:EuropeMember
2020-07-01
2020-09-30
0000830656
srt:EuropeMember
2021-01-01
2021-09-30
0000830656
srt:EuropeMember
2020-01-01
2020-09-30
0000830656
srt:AsiaMember
2021-07-01
2021-09-30
0000830656
srt:AsiaMember
2020-07-01
2020-09-30
0000830656
srt:AsiaMember
2021-01-01
2021-09-30
0000830656
srt:AsiaMember
2020-01-01
2020-09-30
0000830656
PBIO:PrimaryGeographicalMarketsMember
2021-07-01
2021-09-30
0000830656
PBIO:PrimaryGeographicalMarketsMember
2020-07-01
2020-09-30
0000830656
PBIO:PrimaryGeographicalMarketsMember
2021-01-01
2021-09-30
0000830656
PBIO:PrimaryGeographicalMarketsMember
2020-01-01
2020-09-30
0000830656
PBIO:HardwareMember
2021-07-01
2021-09-30
0000830656
PBIO:HardwareMember
2020-07-01
2020-09-30
0000830656
PBIO:HardwareMember
2021-01-01
2021-09-30
0000830656
PBIO:HardwareMember
2020-01-01
2020-09-30
0000830656
PBIO:ConsumablesMember
2021-07-01
2021-09-30
0000830656
PBIO:ConsumablesMember
2020-07-01
2020-09-30
0000830656
PBIO:ConsumablesMember
2021-01-01
2021-09-30
0000830656
PBIO:ConsumablesMember
2020-01-01
2020-09-30
0000830656
PBIO:ContractResearchServicesMember
2021-07-01
2021-09-30
0000830656
PBIO:ContractResearchServicesMember
2020-07-01
2020-09-30
0000830656
PBIO:ContractResearchServicesMember
2021-01-01
2021-09-30
0000830656
PBIO:ContractResearchServicesMember
2020-01-01
2020-09-30
0000830656
PBIO:SamplePreparationAccessoriesMember
2021-07-01
2021-09-30
0000830656
PBIO:SamplePreparationAccessoriesMember
2020-07-01
2020-09-30
0000830656
PBIO:SamplePreparationAccessoriesMember
2021-01-01
2021-09-30
0000830656
PBIO:SamplePreparationAccessoriesMember
2020-01-01
2020-09-30
0000830656
PBIO:TechnicalSupportExtendedServiceContractsMember
2021-07-01
2021-09-30
0000830656
PBIO:TechnicalSupportExtendedServiceContractsMember
2020-07-01
2020-09-30
0000830656
PBIO:TechnicalSupportExtendedServiceContractsMember
2021-01-01
2021-09-30
0000830656
PBIO:TechnicalSupportExtendedServiceContractsMember
2020-01-01
2020-09-30
0000830656
us-gaap:ShippingAndHandlingMember
2021-07-01
2021-09-30
0000830656
us-gaap:ShippingAndHandlingMember
2020-07-01
2020-09-30
0000830656
us-gaap:ShippingAndHandlingMember
2021-01-01
2021-09-30
0000830656
us-gaap:ShippingAndHandlingMember
2020-01-01
2020-09-30
0000830656
PBIO:OthersMember
2021-07-01
2021-09-30
0000830656
PBIO:OthersMember
2020-07-01
2020-09-30
0000830656
PBIO:OthersMember
2021-01-01
2021-09-30
0000830656
PBIO:OthersMember
2020-01-01
2020-09-30
0000830656
PBIO:MajorProductsServicesLinesMember
2021-07-01
2021-09-30
0000830656
PBIO:MajorProductsServicesLinesMember
2020-07-01
2020-09-30
0000830656
PBIO:MajorProductsServicesLinesMember
2021-01-01
2021-09-30
0000830656
PBIO:MajorProductsServicesLinesMember
2020-01-01
2020-09-30
0000830656
PBIO:TransferredAtAPointInTimeMember
2021-07-01
2021-09-30
0000830656
PBIO:TransferredAtAPointInTimeMember
2020-07-01
2020-09-30
0000830656
PBIO:TransferredAtAPointInTimeMember
2021-01-01
2021-09-30
0000830656
PBIO:TransferredAtAPointInTimeMember
2020-01-01
2020-09-30
0000830656
PBIO:TransferredOverAtTimeMember
2021-07-01
2021-09-30
0000830656
PBIO:TransferredOverAtTimeMember
2020-07-01
2020-09-30
0000830656
PBIO:TransferredOverAtTimeMember
2021-01-01
2021-09-30
0000830656
PBIO:TransferredOverAtTimeMember
2020-01-01
2020-09-30
0000830656
PBIO:TimingOfRevenueRecognitionMember
2021-07-01
2021-09-30
0000830656
PBIO:TimingOfRevenueRecognitionMember
2020-07-01
2020-09-30
0000830656
PBIO:TimingOfRevenueRecognitionMember
2021-01-01
2021-09-30
0000830656
PBIO:TimingOfRevenueRecognitionMember
2020-01-01
2020-09-30
0000830656
PBIO:TwoThousandAndTwentyOneMember
2021-09-30
0000830656
PBIO:TwoThousandAndTwentyTwoMember
2021-09-30
0000830656
PBIO:TopFiveCustomersMember
us-gaap:SalesRevenueNetMember
us-gaap:CustomerConcentrationRiskMember
2021-07-01
2021-09-30
0000830656
PBIO:TopFiveCustomersMember
us-gaap:SalesRevenueNetMember
us-gaap:CustomerConcentrationRiskMember
2020-07-01
2020-09-30
0000830656
PBIO:FederalAgenciesMember
us-gaap:SalesRevenueNetMember
us-gaap:CustomerConcentrationRiskMember
2021-07-01
2021-09-30
0000830656
PBIO:FederalAgenciesMember
us-gaap:SalesRevenueNetMember
us-gaap:CustomerConcentrationRiskMember
2020-07-01
2020-09-30
0000830656
PBIO:TopFiveCustomersMember
us-gaap:SalesRevenueNetMember
us-gaap:CustomerConcentrationRiskMember
2021-01-01
2021-09-30
0000830656
PBIO:TopFiveCustomersMember
us-gaap:SalesRevenueNetMember
us-gaap:CustomerConcentrationRiskMember
2020-01-01
2020-09-30
0000830656
PBIO:FederalAgenciesMember
us-gaap:SalesRevenueNetMember
us-gaap:CustomerConcentrationRiskMember
2021-01-01
2021-09-30
0000830656
PBIO:FederalAgenciesMember
us-gaap:SalesRevenueNetMember
us-gaap:CustomerConcentrationRiskMember
2020-01-01
2020-09-30
0000830656
PBIO:TopFiveCustomersMember
us-gaap:AccountsReceivableMember
us-gaap:CustomerConcentrationRiskMember
2021-01-01
2021-09-30
0000830656
PBIO:TopFiveCustomersMember
us-gaap:AccountsReceivableMember
us-gaap:CustomerConcentrationRiskMember
2020-01-01
2020-12-31
0000830656
PBIO:FederalAgenciesMember
us-gaap:AccountsReceivableMember
us-gaap:CustomerConcentrationRiskMember
2021-01-01
2021-09-30
0000830656
PBIO:FederalAgenciesMember
us-gaap:AccountsReceivableMember
us-gaap:CustomerConcentrationRiskMember
2020-01-01
2020-12-31
0000830656
PBIO:NexityGlobalSAMember
2021-01-01
2021-09-30
0000830656
PBIO:NexityGlobalSAMember
2021-09-30
0000830656
PBIO:EmployeeStockOptionsMember
2021-01-01
2021-09-30
0000830656
PBIO:EmployeeStockOptionsMember
2020-01-01
2020-09-30
0000830656
us-gaap:ConvertibleDebtSecuritiesMember
2021-01-01
2021-09-30
0000830656
us-gaap:ConvertibleDebtSecuritiesMember
2020-01-01
2020-09-30
0000830656
PBIO:CommonStockWarrantsMember
2021-01-01
2021-09-30
0000830656
PBIO:CommonStockWarrantsMember
2020-01-01
2020-09-30
0000830656
PBIO:SeriesDConvertiblePreferredStockMember
2021-01-01
2021-09-30
0000830656
PBIO:SeriesDConvertiblePreferredStockMember
2020-01-01
2020-09-30
0000830656
PBIO:SeriesGConvertiblePreferredStockMember
2021-01-01
2021-09-30
0000830656
PBIO:SeriesGConvertiblePreferredStockMember
2020-01-01
2020-09-30
0000830656
PBIO:SeriesHConvertiblePreferredStockMember
2021-01-01
2021-09-30
0000830656
PBIO:SeriesHConvertiblePreferredStockMember
2020-01-01
2020-09-30
0000830656
PBIO:SeriesHTwoConvertiblePreferredStockMember
2021-01-01
2021-09-30
0000830656
PBIO:SeriesHTwoConvertiblePreferredStockMember
2020-01-01
2020-09-30
0000830656
PBIO:SeriesJConvertiblePreferredStockMember
2021-01-01
2021-09-30
0000830656
PBIO:SeriesJConvertiblePreferredStockMember
2020-01-01
2020-09-30
0000830656
PBIO:SeriesKConvertiblePreferredStockMember
2021-01-01
2021-09-30
0000830656
PBIO:SeriesKConvertiblePreferredStockMember
2020-01-01
2020-09-30
0000830656
PBIO:SeriesAAConvertiblePreferredStockMember
2021-01-01
2021-09-30
0000830656
PBIO:SeriesAAConvertiblePreferredStockMember
2020-01-01
2020-09-30
0000830656
us-gaap:CostOfSalesMember
2021-07-01
2021-09-30
0000830656
us-gaap:CostOfSalesMember
2020-07-01
2020-09-30
0000830656
us-gaap:CostOfSalesMember
2021-01-01
2021-09-30
0000830656
us-gaap:CostOfSalesMember
2020-01-01
2020-09-30
0000830656
us-gaap:ResearchAndDevelopmentExpenseMember
2021-07-01
2021-09-30
0000830656
us-gaap:ResearchAndDevelopmentExpenseMember
2020-07-01
2020-09-30
0000830656
us-gaap:ResearchAndDevelopmentExpenseMember
2021-01-01
2021-09-30
0000830656
us-gaap:ResearchAndDevelopmentExpenseMember
2020-01-01
2020-09-30
0000830656
us-gaap:SellingAndMarketingExpenseMember
2021-07-01
2021-09-30
0000830656
us-gaap:SellingAndMarketingExpenseMember
2020-07-01
2020-09-30
0000830656
us-gaap:SellingAndMarketingExpenseMember
2021-01-01
2021-09-30
0000830656
us-gaap:SellingAndMarketingExpenseMember
2020-01-01
2020-09-30
0000830656
us-gaap:GeneralAndAdministrativeExpenseMember
2021-07-01
2021-09-30
0000830656
us-gaap:GeneralAndAdministrativeExpenseMember
2020-07-01
2020-09-30
0000830656
us-gaap:GeneralAndAdministrativeExpenseMember
2021-01-01
2021-09-30
0000830656
us-gaap:GeneralAndAdministrativeExpenseMember
2020-01-01
2020-09-30
0000830656
us-gaap:EquitySecuritiesMember
2021-09-30
0000830656
us-gaap:EquitySecuritiesMember
us-gaap:FairValueInputsLevel1Member
2021-09-30
0000830656
us-gaap:EquitySecuritiesMember
us-gaap:FairValueInputsLevel2Member
2021-09-30
0000830656
us-gaap:EquitySecuritiesMember
us-gaap:FairValueInputsLevel3Member
2021-09-30
0000830656
us-gaap:FairValueInputsLevel1Member
2021-09-30
0000830656
us-gaap:FairValueInputsLevel2Member
2021-09-30
0000830656
us-gaap:FairValueInputsLevel3Member
2021-09-30
0000830656
us-gaap:EquitySecuritiesMember
2020-12-31
0000830656
us-gaap:EquitySecuritiesMember
us-gaap:FairValueInputsLevel1Member
2020-12-31
0000830656
us-gaap:EquitySecuritiesMember
us-gaap:FairValueInputsLevel2Member
2020-12-31
0000830656
us-gaap:EquitySecuritiesMember
us-gaap:FairValueInputsLevel3Member
2020-12-31
0000830656
us-gaap:FairValueInputsLevel1Member
2020-12-31
0000830656
us-gaap:FairValueInputsLevel2Member
2020-12-31
0000830656
us-gaap:FairValueInputsLevel3Member
2020-12-31
0000830656
PBIO:CorporateOfficeMember
2020-01-01
2020-12-31
0000830656
PBIO:TargetDiscoveryIncMember
2021-01-01
2021-09-30
0000830656
us-gaap:ConvertibleDebtMember
2021-01-01
2021-09-30
0000830656
srt:MinimumMember
us-gaap:ConvertibleDebtMember
2021-01-01
2021-09-30
0000830656
srt:MaximumMember
us-gaap:ConvertibleDebtMember
2021-01-01
2021-09-30
0000830656
srt:MinimumMember
us-gaap:ConvertibleDebtMember
2021-09-30
0000830656
srt:MaximumMember
us-gaap:ConvertibleDebtMember
2021-09-30
0000830656
us-gaap:ConvertibleCommonStockMember
2021-09-30
0000830656
PBIO:ConvertibleDebtOneMember
PBIO:FixedRateConvertibleNotesMember
2021-01-01
2021-09-30
0000830656
PBIO:ConvertibleDebtOneMember
PBIO:FixedRateConvertibleNotesMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtTwoMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtTwoMember
2021-09-30
0000830656
PBIO:ConvertibleDebtThreeMember
PBIO:FixedRateConvertibleNotesMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtThreeMember
2021-09-30
0000830656
PBIO:ConvertibleDebtFourMember
PBIO:FixedRateConvertibleNotesMember
2021-01-01
2021-09-30
0000830656
PBIO:ConvertibleDebtFourMember
PBIO:FixedRateConvertibleNotesMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtFiveMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtFiveMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtSixMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtSixMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtSevenMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtSevenMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtEightMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtEightMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtNineMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtNineMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtTenMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtTenMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtElevenMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtElevenMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtTwelveMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtTwelveMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtThirteenMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtThirteenMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtFourteenMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtFourteenMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtFifteenMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtFifteenMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtSixteenMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtSixteenMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtSeventeenMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtSeventeenMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtEighteenMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtEighteenMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtNineteenMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtNineteenMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtTwentyMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtTwentyMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtTwentyOneMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtTwentyOneMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtTwentyTwoMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtTwentyTwoMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtTwentyThreeMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtTwentyThreeMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtTwentyFourMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtTwentyFourMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtTwentyFiveMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtTwentyFiveMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtTwentySixMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtTwentySixMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtTwentySevenMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtTwentySevenMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtTwentyEightMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtTwentyEightMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtTwentyNineMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtTwentyNineMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtThirtyMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtThirtyMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtThirtyOneMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtThirtyOneMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtThirtyTwoMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtThirtyTwoMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtThirtyThreeMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtThirtyThreeMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtThirtyFourMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtThirtyFourMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtThirtyFiveMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtThirtyFiveMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtThirtySixMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtThirtySixMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtThirtySevenMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtThirtySevenMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtThirtyEightMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtThirtyEightMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtThirtyNineMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtThirtyNineMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtFortyMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtFortyMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtFortyOneMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtFortyOneMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtFortyTwoMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtFortyTwoMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtFortyThreeMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtFortyThreeMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtFortyFourMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtFortyFourMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtFortyFiveMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtFortyFiveMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtFortySixMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtFortySixMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtFortySevenMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtFortySevenMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtFortyEightMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtFortyEightMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtFortyNineMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtFortyNineMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtFiftyMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtFiftyMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtFiftyOneMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtFiftyOneMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtFiftyTwoMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtFiftyTwoMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtFiftyThreeMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtFiftyThreeMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtFiftyFourMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtFiftyFourMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtFiftyFiveMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtFiftyFiveMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtFiftySixMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtFiftySixMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtFiftySevenMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtFiftySevenMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtFiftyEightMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtFiftyEightMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtFiftyNineMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtFiftyNineMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtSixtyMember
2021-01-01
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
PBIO:ConvertibleDebtSixtyMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
2021-09-30
0000830656
PBIO:FixedRateConvertibleNotesMember
2021-01-01
2021-09-30
0000830656
PBIO:OneLenderMember
2021-09-30
0000830656
PBIO:LenderMember
2021-09-30
0000830656
us-gaap:ConvertibleDebtMember
2021-09-30
0000830656
PBIO:LendersMember
PBIO:StandstillAndForbearanceAgreementsMember
2021-06-30
0000830656
PBIO:StandstillAndForbearanceAgreementsMember
2021-03-31
0000830656
PBIO:StandstillAndForbearanceAgreementsMember
2021-04-16
0000830656
PBIO:StandstillAndForbearanceAgreementsMember
PBIO:FiveNotesMember
PBIO:ThreeLendersMember
2021-07-01
2021-09-30
0000830656
PBIO:StandstillAndForbearanceAgreementsMember
PBIO:FiveNotesMember
2021-07-01
2021-09-30
0000830656
PBIO:StandstillAndForbearanceAgreementsMember
2021-09-30
0000830656
PBIO:NewLoanMember
2021-01-01
2021-09-30
0000830656
PBIO:NewLoanMember
2021-09-30
0000830656
PBIO:PrivateInvestorMember
PBIO:NonConvertibleLoansMember
2019-09-09
2020-02-28
0000830656
PBIO:PrivateInvestorMember
PBIO:NonConvertibleLoansMember
2020-01-01
2020-12-31
0000830656
PBIO:PrivateInvestorMember
PBIO:NonConvertibleLoansMember
us-gaap:WarrantMember
2020-12-31
0000830656
PBIO:PrivateInvestorMember
PBIO:NonConvertibleLoansMember
us-gaap:WarrantMember
2020-01-01
2020-12-31
0000830656
PBIO:PrivateInvestorMember
PBIO:NonConvertibleLoansMember
2021-09-30
0000830656
PBIO:HolderMember
PBIO:NonConvertibleLoansMember
2019-09-29
2019-10-01
0000830656
PBIO:NonConvertibleLoansMember
PBIO:HolderMember
2019-10-01
0000830656
PBIO:PrivateInvestorMember
PBIO:NonConvertibleLoansMember
2019-10-10
2019-10-11
0000830656
PBIO:NonConvertibleLoansMember
PBIO:PrivateInvestorMember
2019-10-11
0000830656
PBIO:PrivateInvestorMember
PBIO:NonConvertibleLoansMember
PBIO:SeriesAAPreferredStockMember
2021-01-01
2021-09-30
0000830656
PBIO:PrivateInvestorMember
PBIO:NonConvertibleLoansMember
us-gaap:WarrantMember
2021-09-30
0000830656
srt:MinimumMember
PBIO:MerchantAgreementsMember
2021-09-30
0000830656
srt:MaximumMember
PBIO:MerchantAgreementsMember
2021-09-30
0000830656
PBIO:MerchantAgreementsFourMember
2021-01-01
2021-09-30
0000830656
PBIO:MerchantAgreementsFourMember
2021-09-30
0000830656
PBIO:MerchantAgreementsFiveMember
2021-01-01
2021-09-30
0000830656
PBIO:MerchantAgreementsFiveMember
2021-09-30
0000830656
PBIO:MerchantAgreementsSixMember
2021-01-01
2021-09-30
0000830656
PBIO:MerchantAgreementsSixMember
2021-09-30
0000830656
PBIO:MerchantAgreementsSevenMember
2021-01-01
2021-09-30
0000830656
PBIO:MerchantAgreementsSevenMember
2021-09-30
0000830656
PBIO:MerchantAgreementsOneMember
2020-01-01
2020-12-31
0000830656
PBIO:MerchantAgreementsOneMember
2020-12-31
0000830656
PBIO:MerchantAgreementsTwoMember
2020-01-01
2020-12-31
0000830656
PBIO:MerchantAgreementsTwoMember
2020-12-31
0000830656
2020-01-01
2020-12-31
0000830656
PBIO:ShortTermNonConvertibleLoanMember
2021-01-01
2021-09-30
0000830656
srt:MaximumMember
PBIO:ShortTermNonConvertibleLoanMember
2021-09-30
0000830656
srt:MinimumMember
PBIO:ShortTermNonConvertibleLoanMember
2021-09-30
0000830656
PBIO:ShortTermNonConvertibleLoanMember
PBIO:SeriesAAPreferredStockMember
2021-01-01
2021-09-30
0000830656
PBIO:ShortTermNonConvertibleLoanMember
PBIO:SeriesAAPreferredStockMember
2021-09-30
0000830656
PBIO:SmallBusinessAdministrationMember
2021-09-30
0000830656
PBIO:SmallBusinessAdministrationMember
2021-01-01
2021-09-30
0000830656
PBIO:EconomicInjuryDisasterLoanProgramMember
2021-09-30
0000830656
PBIO:EconomicInjuryDisasterLoanProgramMember
2021-01-01
2021-09-30
0000830656
us-gaap:PreferredStockMember
2021-09-30
0000830656
us-gaap:PreferredStockMember
2021-06-30
0000830656
PBIO:SeriesAJuniorParticipatingPreferredStockMember
2021-09-30
0000830656
PBIO:SeriesAConvertiblePreferredStockMember
2021-09-30
0000830656
PBIO:SeriesBConvertiblePreferredStockMember
2021-09-30
0000830656
PBIO:SeriesCConvertiblePreferredStockMember
2021-09-30
0000830656
PBIO:SeriesEConvertiblePreferredStockMember
2021-09-30
0000830656
PBIO:SeriesHTwoConvertiblePreferredStockMember
2021-09-30
0000830656
PBIO:SecuritiesPurchaseAgreementMember
PBIO:SeriesAAPreferredStockMember
PBIO:AccreditedMember
2021-01-01
2021-09-30
0000830656
PBIO:SecuritiesPurchaseAgreementMember
PBIO:SeriesAAPreferredStockMember
PBIO:AccreditedMember
2021-09-30
0000830656
PBIO:TwoThousandThirteenEquityIncentivePlanMember
2013-12-12
0000830656
PBIO:TwoThousandThirteenEquityIncentivePlanMember
2021-09-30
0000830656
PBIO:StockOptionsMember
2020-12-31
0000830656
us-gaap:WarrantMember
2020-12-31
0000830656
PBIO:StockOptionsMember
2021-01-01
2021-09-30
0000830656
us-gaap:WarrantMember
2021-01-01
2021-09-30
0000830656
PBIO:StockOptionsMember
2021-09-30
0000830656
us-gaap:WarrantMember
2021-09-30
0000830656
PBIO:StockOptionsIssuanceMember
2021-01-01
2021-09-30
0000830656
PBIO:StockOptionsIssuanceMember
2021-09-30
0000830656
us-gaap:EmployeeStockOptionMember
2021-06-30
0000830656
us-gaap:EmployeeStockOptionMember
2021-09-30
0000830656
us-gaap:EmployeeStockOptionMember
2021-01-01
2021-09-30
0000830656
PBIO:LoansOneMember
2021-01-01
2021-09-30
0000830656
PBIO:LoansOneMember
2021-09-30
0000830656
PBIO:LoansTwoMember
2021-01-01
2021-09-30
0000830656
PBIO:LoansTwoMember
2021-09-30
0000830656
PBIO:LoansThreeMember
2021-01-01
2021-09-30
0000830656
PBIO:LoansThreeMember
2021-09-30
0000830656
PBIO:LoansFourMember
2021-01-01
2021-09-30
0000830656
PBIO:LoansFourMember
2021-09-30
0000830656
PBIO:LoansFiveMember
2021-01-01
2021-09-30
0000830656
PBIO:LoansFiveMember
2021-09-30
0000830656
PBIO:LendersMember
2021-01-01
2021-09-30
0000830656
2020-12-22
2020-12-23
0000830656
PBIO:LendersMember
2021-09-30
0000830656
PBIO:DebtSettlementMember
2021-01-01
2021-09-30
0000830656
us-gaap:CommonStockMember
2021-01-01
2021-09-30
0000830656
srt:MinimumMember
2021-09-30
0000830656
srt:MaximumMember
2021-09-30
0000830656
PBIO:NonConvertibleDebtMember
PBIO:SeriesAAPreferredStockMember
2021-01-01
2021-09-30
0000830656
PBIO:NonConvertibleDebtMember
us-gaap:WarrantMember
2021-09-30
0000830656
PBIO:NonConvertibleDebtMember
2021-01-01
2021-09-30
0000830656
PBIO:SeriesAAConvertiblePreferredStockMember
2020-01-01
2020-09-30
0000830656
PBIO:AccreditedInvestorsAndConsultantsMember
2020-01-01
2020-09-30
0000830656
PBIO:DebtExtentionAndInterestPaymentsMember
2020-01-01
2020-09-30
0000830656
PBIO:SettlementAccuruedLiabilityMember
2020-01-01
2020-09-30
0000830656
us-gaap:WarrantMember
srt:MinimumMember
2021-01-01
2021-09-30
0000830656
us-gaap:WarrantMember
srt:MaximumMember
2021-01-01
2021-09-30
0000830656
us-gaap:SubsequentEventMember
2021-10-01
2021-11-11
0000830656
us-gaap:SubsequentEventMember
2021-11-11
0000830656
us-gaap:SubsequentEventMember
us-gaap:ConvertibleDebtMember
2021-10-01
2021-11-11
0000830656
us-gaap:SubsequentEventMember
PBIO:LendersMember
2021-10-01
2021-11-11
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
xbrli:pure
PBIO:Integer
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
10-Q
(Mark
One)
☒
Quarterly Report Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
For
the quarterly period ended September 30, 2021
or
☐
Transition Report Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
For
the transition period from _____________ to _____________
Commission
File Number 001-38185
PRESSURE
BIOSCIENCES, INC.
(Exact
name of registrant as specified in its charter)
Massachusetts |
|
04-2652826 |
(State
or other jurisdiction of |
|
(I.R.S.
Employer |
incorporation
or organization) |
|
Identification
No.) |
14
Norfolk Avenue
South
Easton, Massachusetts |
|
02375 |
(Address
of principal executive offices) |
|
(Zip
Code) |
(508)
230-1828
(Registrant’s
telephone number, including area code)
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
N/A |
|
N/A
|
|
N/A |
Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days.
☒
Yes ☐ No
Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit such files).
☒
Yes ☐ No
Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting
company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,”
and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):
|
Large
accelerated filer |
☐ |
Accelerated
filer |
☐ |
|
Non-accelerated
Filer |
☒ |
Smaller
Reporting Company |
☒ |
|
Emerging
Growth Company |
☐ |
|
|
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate
by check mark whether the registrant is a shell company (as defined in Exchange Act Rule 12b-2 of the Exchange Act).
☐
Yes ☒ No
The
number of shares outstanding of the Issuer’s common stock as of November 10, 2021 was 7,391,391.
TABLE
OF CONTENTS
PART
I - FINANCIAL INFORMATION
Item
1. Financial Statements
PRESSURE
BIOSCIENCES, INC. AND SUBSIDIARIES
CONSOLIDATED
BALANCE SHEETS
(UNAUDITED)
| |
September 30,
2021 | | |
December 31,
2020 | |
ASSETS | |
| | | |
| | |
CURRENT ASSETS | |
| | | |
| | |
Cash and cash equivalents | |
$ | 663,651 | | |
$ | 18,540 | |
Accounts receivable | |
| 538,632 | | |
| 131,228 | |
Inventories, net of $342,496 reserve at September 30, 2021 and December 31, 2020 | |
| 796,418 | | |
| 592,767 | |
Prepaid expenses and other current assets | |
| 620,960 | | |
| 314,936 | |
Total current assets | |
| 2,619,661 | | |
| 1,057,471 | |
Investment in equity securities | |
| 112,550 | | |
| 517,001 | |
Property and equipment, net | |
| 2,366 | | |
| 16,490 | |
Right of use asset leases | |
| 173,274 | | |
| 221,432 | |
Intangible assets, net | |
| 425,481 | | |
| 490,385 | |
TOTAL ASSETS | |
$ | 3,333,332 | | |
$ | 2,302,779 | |
LIABILITIES AND STOCKHOLDERS’ DEFICIT | |
| | | |
| | |
CURRENT LIABILITIES | |
| | | |
| | |
Accounts payable | |
$ | 418,020 | | |
$ | 771,945 | |
Accrued employee compensation | |
| 142,375 | | |
| 417,578 | |
Accrued professional fees and other | |
| 2,021,783 | | |
| 2,037,806 | |
Other current liabilities | |
| 7,108,447 | | |
| 6,330,722 | |
Deferred revenue | |
| 44,176 | | |
| 47,328 | |
Convertible debt, net of unamortized discounts of $2,692,163 and $3,948,167, respectively | |
| 11,760,299 | | |
| 7,545,670 | |
Other debt, net of unamortized discounts of $1,291 and $0, respectively | |
| 1,070,526 | | |
| 1,135,469 | |
Operating lease liability | |
| 71,301 | | |
| 65,193 | |
Other related party debt | |
| 38,000 | | |
| 166,000 | |
Total current liabilities | |
| 22,674,927 | | |
| 18,517,711 | |
LONG TERM LIABILITIES | |
| | | |
| | |
Long term debt | |
| 527,038 | | |
| 527,039 | |
Operating lease liability – long term | |
| 101,973 | | |
| 156,239 | |
Deferred revenue | |
| 8,654 | | |
| 19,382 | |
TOTAL LIABILITIES | |
| 23,312,592 | | |
| 19,220,371 | |
COMMITMENTS AND CONTINGENCIES (Note 4) | |
| - | | |
| | |
STOCKHOLDERS’ DEFICIT | |
| | | |
| | |
Series D Convertible Preferred Stock, $.01 par value; 850 shares authorized; 300 shares issued and outstanding on September 30, 2021 and December 31, 2020, respectively (Liquidation value of $300,000) | |
| 3 | | |
| 3 | |
Series G Convertible Preferred Stock, $.01 par value; 240,000 shares authorized; 80,570 shares issued and outstanding on September 30, 2021 and December 31, 2020, respectively | |
| 806 | | |
| 806 | |
Series H Convertible Preferred Stock, $.01 par value; 10,000 shares authorized; 10,000 shares issued and outstanding on September 30, 2021 and December 31, 2020, respectively | |
| 100 | | |
| 100 | |
Series H2 Convertible Preferred Stock, $.01 par value; 21 shares authorized; 21 shares issued and outstanding on September 30, 2021 and December 31, 2020, respectively | |
| - | | |
| - | |
Series J Convertible Preferred Stock, $.01 par value; 6,250 shares authorized; 3,458 shares issued and outstanding on September 30, 2021 and December 31, 2020, respectively | |
| 35 | | |
| 35 | |
Series K Convertible Preferred Stock, $.01 par value; 15,000 shares authorized; 6,880 shares issued and outstanding on September 30, 2021 and December 31, 2020, respectively | |
| 68 | | |
| 68 | |
Series AA Convertible Preferred Stock, $.01 par value; 10,000 shares authorized; 8,649 and 8,043 shares issued and outstanding on September 30, 2021 and December 31, 2020, respectively | |
| 87 | | |
| 81 | |
Convertible preferred stock | |
| | | |
| | |
Common stock, $.01 par value; 100,000,000 shares authorized; 8,345,120 and 4,168,324 shares issued and outstanding on September 30, 2021 and December 31, 2020 respectively | |
| 83,451 | | |
| 41,683 | |
Warrants to acquire common stock | |
| 31,607,879 | | |
| 29,192,471 | |
Additional paid-in capital | |
| 62,307,524 | | |
| 50,312,968 | |
Accumulated deficit | |
| (113,979,213 | ) | |
| (96,465,807 | ) |
Total stockholders’ deficit | |
| (19,979,260 | ) | |
| (16,917,592 | ) |
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT | |
$ | 3,333,332 | | |
$ | 2,302,779 | |
The
accompanying notes are an integral part of these unaudited consolidated financial statements
PRESSURE
BIOSCIENCES, INC. AND SUBSIDIARIES
CONSOLIDATED
STATEMENTS OF OPERATIONS
(UNAUDITED)
| |
2021 | | |
2020 | | |
2021 | | |
2020 | |
| |
For the Three Months Ended
September 30, | | |
For the Nine Months Ended
September 30, | |
| |
2021 | | |
2020 | | |
2021 | | |
2020 | |
Revenue: | |
| | |
| | |
| | |
| |
Products, services, other | |
$ | 518,365 | | |
$ | 533,862 | | |
$ | 1,687,166 | | |
$ | 1,055,889 | |
Total revenue | |
| 518,365 | | |
| 533,862 | | |
| 1,687,166 | | |
| 1,055,889 | |
| |
| | | |
| | | |
| | | |
| | |
Costs and expenses: | |
| | | |
| | | |
| | | |
| | |
Cost of products and services | |
| 258,170 | | |
| 247,013 | | |
| 771,105 | | |
| 557,041 | |
Research and development | |
| 282,622 | | |
| 247,432 | | |
| 839,072 | | |
| 807,724 | |
Selling and marketing | |
| 66,068 | | |
| 173,372 | | |
| 252,209 | | |
| 524,586 | |
General and administrative | |
| 1,154,063 | | |
| 684,807 | | |
| 2,788,779 | | |
| 2,711,032 | |
Total operating costs and expenses | |
| 1,760,923 | | |
| 1,352,624 | | |
| 4,651,165 | | |
| 4,600,383 | |
| |
| | | |
| | | |
| | | |
| | |
Operating loss | |
| (1,242,558 | ) | |
| (818,762 | ) | |
| (2,963,999 | ) | |
| (3,544,494 | ) |
| |
| | | |
| | | |
| | | |
| | |
Other (expense) income: | |
| | | |
| | | |
| | | |
| | |
Interest expense, net | |
| (3,330,101 | ) | |
| (2,204,593 | ) | |
| (11,524,306 | ) | |
| (5,501,272 | ) |
Unrealized (loss) gain on investment in equity securities | |
| (162,071 | ) | |
| 140,461 | | |
| (404,451 | ) | |
| 486,723 | |
Loss on extinguishment of liabilities | |
| (277,010 | ) | |
| (395,854 | ) | |
| (1,500,395 | ) | |
| (3,242,372 | ) |
Other income | |
| 60,627 | | |
| - | | |
| 119,280 | | |
| - | |
Total other expense | |
| (3,708,555 | ) | |
| (2,459,986 | ) | |
| (13,309,872 | ) | |
| (8,256,921 | ) |
| |
| | | |
| | | |
| | | |
| | |
Net loss | |
| (4,951,113 | ) | |
| (3,278,748 | ) | |
| (16,273,871 | ) | |
| (11,801,415 | ) |
Deemed dividends on beneficial conversion feature | |
| (815,914 | ) | |
| - | | |
| (873,798 | ) | |
| - | |
Preferred stock dividends | |
| (432,149 | ) | |
| (396,970 | ) | |
| (1,239,535 | ) | |
| (1,118,526 | ) |
Net loss attributable to common stockholders | |
$ | (6,199,176 | ) | |
$ | (3,675,718 | ) | |
$ | (18,387,204 | ) | |
$ | (12,919,941 | ) |
Basic and diluted net loss per share attributable to common stockholders | |
$ | (0.82 | ) | |
$ | (1.02 | ) | |
$ | (3.02
| ) | |
$ | (4.22 | ) |
| |
| | | |
| | | |
| | | |
| | |
Weighted average common stock shares outstanding used in the basic and diluted net loss per share calculation | |
| 7,561,728 | | |
| 3,612,958 | | |
| 6,083,017 | | |
| 3,059,095 | |
The
accompanying notes are an integral part of these unaudited consolidated financial statements
PRESSURE
BIOSCIENCES, INC. AND SUBSIDIARIES
CONSOLIDATED
STATEMENTS OF CASH FLOWS
(UNAUDITED)
| |
2021 | | |
2020 | |
| |
For the Nine Months Ended | |
| |
September 30, | |
| |
2021 | | |
2020 | |
CASH FLOWS FROM OPERATING ACTIVITIES: | |
| | | |
| | |
Net loss | |
$ | (16,273,871 | ) | |
$ | (11,801,415 | ) |
Adjustments to reconcile net loss to net cash used in operating activities: | |
| | | |
| | |
Gain on loan forgiveness | |
| (367,039 | ) | |
| - | |
Non-cash lease expense | |
| 48,158 | | |
| 55,628 | |
Common stock and warrants issued for interest and extension fees | |
| 6,208,696 | | |
| 242,350 | |
Depreciation and amortization | |
| 83,531 | | |
| 103,424 | |
Accretion of interest and amortization of debt discount | |
| 5,308,424 | | |
| 3,454,470 | |
Loss on extinguishment of accrued liabilities and debt | |
| 23,004 | | |
| 1,036,638 | |
Stock-based compensation expense | |
| 219,943 | | |
| 373,652 | |
Loss (Gain) on investment in equity securities | |
| 404,451 | | |
| (486,723 | ) |
Common stock issued for services | |
| 579,512 | | |
| 87,963 | |
Changes in operating assets and liabilities: | |
| | | |
| | |
Accounts receivable | |
| (407,404 | ) | |
| (101,057 | ) |
Inventories | |
| (203,651 | ) | |
| 101,511 | |
Prepaid expenses and other assets | |
| (306,024 | ) | |
| 53,810 | |
Accounts payable | |
| (336,675 | ) | |
| (109,445 | ) |
Accrued employee compensation | |
| 39,801 | | |
| (609 | ) |
Operating lease liability | |
| (48,158 | ) | |
| (55,628 | ) |
Deferred revenue and other accrued expenses | |
| 943,400 | | |
| 3,138,667 | |
Net cash used in operating activities | |
| (4,083,902 | ) | |
| (3,906,764 | ) |
| |
| | | |
| | |
CASH FLOWS FROM INVESTING ACTIVITIES: | |
| | | |
| | |
Advance on loan receivable | |
| - | | |
| (801,250 | ) |
Purchases of property plant and equipment | |
| (4,503 | ) | |
| (1,663 | ) |
Net cash used in investing activities | |
| (4,503 | ) | |
| (802,913 | ) |
| |
| | | |
| | |
CASH FLOWS FROM FINANCING ACTIVITIES: | |
| | | |
| | |
Net proceeds from Series AA Convertible Preferred Stock | |
| 1,015,000 | | |
| - | |
Proceeds from stock option exercises | |
| 14,773 | | |
| - | |
Net proceeds from convertible debt | |
| 5,054,500 | | |
| 6,977,800 | |
Net proceeds from non-convertible debt – third party | |
| 1,610,688 | | |
| 990,539 | |
Net proceeds from non-convertible debt – related party | |
| 194,600 | | |
| 38,500 | |
Payments on convertible debt | |
| (1,608,295 | ) | |
| (1,972,007 | ) |
Payments on non-convertible debt – related party | |
| (256,600 | ) | |
| (15,000 | ) |
Payments on non-convertible debt | |
| (1,291,150 | ) | |
| (1,245,028 | ) |
Net cash provided by financing activities | |
| 4,733,516 | | |
| 4,774,804 | |
| |
| | | |
| | |
NET INCREASE IN CASH AND CASH EQUIVALENTS | |
| 645,111 | | |
| 65,127 | |
CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR | |
| 18,540 | | |
| 29,625 | |
CASH AND CASH EQUIVALENTS AT END OF PERIOD | |
$ | 663,651 | | |
$ | 94,752 | |
| |
| | | |
| | |
SUPPLEMENTAL INFORMATION | |
| | | |
| | |
Interest paid in cash | |
$ | 802,084 | | |
$ | 530,009 | |
NON CASH TRANSACTIONS: | |
| | | |
| | |
Common stock issued for non-cash warrant exercise | |
| 363 | | |
| - | |
Loan extension fees and interest added to principal | |
| - | | |
| 152,552 | |
Common stock issued to settle accrued liabilities | |
| - | | |
| 127,855 | |
Common stock issued with debt | |
| 551,198 | | |
| 147,775 | |
Discount from warrants issued with debt | |
| 1,403,546 | | |
| 4,261,055 | |
Common stock issued in lieu of cash for dividend | |
| 114,298 | | |
| 221,374 | |
Preferred stock dividends | |
| 1,239,535 | | |
| 1,118,526 | |
Conversion of debt and interest into common stock | |
| 2,589,990 | | |
| 1,830,543 | |
Discount due to beneficial conversion feature | |
| 1,231,528 | | |
| 1,353,694 | |
Deemed dividend - beneficial conversion feature | |
| 873,798 | | |
| - | |
Conversion of accrued liabilities and debt for Series AA preferred
stock | |
| 500,250 | | |
| 110,000 | |
Common stock issued for debt settlement | |
| - | | |
| 374,550 | |
The
accompanying notes are an integral part of these unaudited consolidated financial statements
PRESSURE
BIOSCIENCES, INC. AND SUBSIDIARIES
CONSOLIDATED
STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT
(UNAUDITED)
|
|
Shares |
|
|
Amount |
|
|
Shares |
|
|
Amount |
|
|
Shares |
|
|
Amount |
|
|
Shares |
|
|
Amount |
|
|
Shares |
|
|
Amount |
|
|
Shares |
|
|
Amount |
|
|
Shares |
|
|
Amount |
|
|
Shares |
|
|
Amount |
|
|
Warrants |
|
|
Capital |
|
|
Deficit |
|
|
Deficit |
|
|
|
Series D
Preferred Stock |
|
|
Series G Preferred Stock |
|
|
Series H Preferred Stock |
|
|
Series H(2) Preferred Stock |
|
|
Series J Preferred Stock |
|
|
Series K Preferred Stock |
|
|
Series AA Preferred Stock |
|
|
Common Stock |
|
|
Stock |
|
|
Additional Paid-In |
|
|
Accumulated |
|
|
Total Stockholders’ |
|
|
|
Shares |
|
|
Amount |
|
|
Shares |
|
|
Amount |
|
|
Shares |
|
|
Amount |
|
|
Shares |
|
|
Amount |
|
|
Shares |
|
|
Amount |
|
|
Shares |
|
|
Amount |
|
|
Shares |
|
|
Amount |
|
|
Shares |
|
|
Amount |
|
|
Warrants |
|
|
Capital |
|
|
Deficit |
|
|
Deficit |
|
BALANCE, December 31, 2019 |
|
|
300 |
|
|
$ |
3 |
|
|
|
80,570 |
|
|
$ |
806 |
|
|
|
10,000 |
|
|
$ |
100 |
|
|
|
21 |
|
|
$ |
- |
|
|
|
3,458 |
|
|
$ |
35 |
|
|
|
6,880 |
|
|
$ |
68 |
|
|
|
7939 |
|
|
$ |
80 |
|
|
|
2,549,620 |
|
|
$ |
25,496 |
|
|
$ |
22,599,177 |
|
|
$ |
44,261,105 |
|
|
$ |
(78,942,277 |
) |
|
$ |
(12,055,407 |
) |
Stock-based compensation |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
241,769 |
|
|
|
- |
|
|
|
241,769 |
|
Issuance
of common stock for non-cash warrant exercise |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock for non-cash warrant exercise, shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock option exercise |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock option exercise, shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series AA Preferred Stock dividend |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
(324,586 |
) |
|
|
(324,586 |
) |
Conversion of debt and interest for common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion of debt and interest for common stock, shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock to settle accrued liabilities |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
66,500 |
|
|
|
665 |
|
|
|
- |
|
|
|
127,190 |
|
|
|
- |
|
|
|
127,855 |
|
Common stock issued for debt settlement |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
10,000 |
|
|
|
100 |
|
|
|
- |
|
|
|
24,900 |
|
|
|
- |
|
|
|
25,000 |
|
Series AA Preferred Stock issued for settlement of liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series AA Preferred Stock issued for settlement of liabilities, shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series AA Preferred Stock offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series AA Preferred Stock offering, shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Beneficial conversion feature on debt |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
404,608 |
|
|
|
- |
|
|
|
404,608 |
|
Beneficial conversion option on convertible preferred stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants issued for debt extension |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
609,143 |
|
|
|
- |
|
|
|
- |
|
|
|
609,143 |
|
Issuance of common stock for debt extension and interest paid in kind |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
38,521 |
|
|
|
385 |
|
|
|
- |
|
|
|
60,175 |
|
|
|
- |
|
|
|
60,560 |
|
Conversion of debt and interest for common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion of debt and interest for common stock, shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants issued with debt |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
1,205,010 |
|
|
|
- |
|
|
|
- |
|
|
|
1,205,010 |
|
Deemed dividend on convertible preferred stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock issued with debt |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock issued with debt, shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(3,953,885 |
) |
|
|
(3,953,885 |
) |
BALANCE, March 31, 2020 |
|
|
300 |
|
|
$ |
3 |
|
|
|
80,570 |
|
|
$ |
806 |
|
|
|
10,000 |
|
|
$ |
100 |
|
|
|
21 |
|
|
$ |
- |
|
|
|
3,458 |
|
|
$ |
35 |
|
|
|
6,880 |
|
|
$ |
68 |
|
|
|
7,939 |
|
|
$ |
80 |
|
|
|
2,664,641 |
|
|
$ |
26,646 |
|
|
$ |
24,413,330 |
|
|
$ |
45,119,747 |
|
|
$ |
(83,220,748 |
) |
|
$ |
(13,659,933 |
) |
Stock-based compensation |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
65,341 |
|
|
|
- |
|
|
|
65,341 |
|
Series AA Preferred Stock dividend |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(396,970 |
) |
|
|
(396,970 |
) |
Beneficial conversion feature on debt |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
577,489 |
|
|
|
- |
|
|
|
577,489 |
|
Issuance of common stock for services |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
25,000 |
|
|
|
250 |
|
|
|
- |
|
|
|
87,713 |
|
|
|
- |
|
|
|
87,963 |
|
Issuance of common stock for interest paid-in-kind |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
42,510 |
|
|
|
425 |
|
|
|
- |
|
|
|
98,799 |
|
|
|
- |
|
|
|
99,224 |
|
Issuance of common stock for dividends paid-in-kind |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
64,388 |
|
|
|
644 |
|
|
|
- |
|
|
|
176,104 |
|
|
|
- |
|
|
|
176,748 |
|
Conversion of debt and interest for common stock |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
410,746 |
|
|
|
4,107 |
|
|
|
- |
|
|
|
1,288,542 |
|
|
|
- |
|
|
|
1,292,649 |
|
Warrants issued with debt |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
- |
|
|
|
1,753,683 |
|
|
|
- |
|
|
|
- |
|
|
|
1,753,683 |
|
Warrants issued for debt extension |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
- |
|
|
|
360,602 |
|
|
|
- |
|
|
|
- |
|
|
|
360,602 |
|
Net loss |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(4,568,782 |
) |
|
|
(4,568,782 |
) |
BALANCE, June 30, 2020 |
|
|
300 |
|
|
$ |
3 |
|
|
|
80,570 |
|
|
$ |
806 |
|
|
|
10,000 |
|
|
$ |
100 |
|
|
|
21 |
|
|
$ |
- |
|
|
|
3,458 |
|
|
$ |
35 |
|
|
|
6,880 |
|
|
$ |
68 |
|
|
|
7,939 |
|
|
$ |
80 |
|
|
|
3,207,285 |
|
|
$ |
32,072 |
|
|
$ |
26,527,615 |
|
|
$ |
47,413,735 |
|
|
$ |
(88,186,500 |
) |
|
$ |
(14,211,986 |
) |
Stock-based compensation |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
66,542 |
|
|
|
- |
|
|
|
66,542 |
|
Issuance of common stock for interest paid-in-kind |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
46,021 |
|
|
|
460 |
|
|
|
- |
|
|
|
82,106 |
|
|
|
- |
|
|
|
82,566 |
|
Issuance of common stock for dividends paid-in-kind |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
23,130 |
|
|
|
232 |
|
|
|
- |
|
|
|
44,394 |
|
|
|
- |
|
|
|
44,626 |
|
Series AA Preferred Stock dividend |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(396,970 |
) |
|
|
(396,970 |
) |
Conversion of debt and interest for common stock |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
299,042 |
|
|
|
2,990 |
|
|
|
- |
|
|
|
534,904 |
|
|
|
- |
|
|
|
537,894 |
|
Warrants issued with debt |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
1,302,362 |
|
|
|
|
|
|
|
- |
|
|
|
1,302,362 |
|
Conversion of debt into Series AA convertible preferred stock |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
44 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
38,783 |
|
|
|
71,217 |
|
|
|
- |
|
|
|
110,000 |
|
Beneficial conversion feature on debt |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
371,597 |
|
|
|
- |
|
|
|
371,597 |
|
Common stock issued for debt settlement |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
178,778 |
|
|
|
1,788 |
|
|
|
- |
|
|
|
347,762 |
|
|
|
- |
|
|
|
349,550 |
|
Warrants issued for debt settlement |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
338,412 |
|
|
|
- |
|
|
|
- |
|
|
|
338,412 |
|
Common Stock issued with debt |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
85,000 |
|
|
|
850 |
|
|
|
- |
|
|
|
146,925 |
|
|
|
- |
|
|
|
147,775 |
|
Net loss |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(3,278,748 |
) |
|
|
(3,278,748 |
) |
BALANCE, September 30, 2020 |
|
|
300 |
|
|
$ |
3 |
|
|
|
80,570 |
|
|
$ |
806 |
|
|
|
10,000 |
|
|
$ |
100 |
|
|
|
21 |
|
|
$ |
- |
|
|
|
3,458 |
|
|
$ |
35 |
|
|
|
6,880 |
|
|
$ |
68 |
|
|
|
7,983 |
|
|
$ |
80 |
|
|
|
3,839,256 |
|
|
$ |
38,392 |
|
|
$ |
28,207,172 |
|
|
$ |
49,079,182 |
|
|
$ |
(91,862,218 |
) |
|
$ |
(14,536,380 |
) |
|
|
Series
D Preferred Stock |
|
|
Series
G Preferred Stock |
|
|
Series
H Preferred Stock |
|
|
Series
H(2) Preferred Stock |
|
|
Series
J Preferred Stock |
|
|
Series
K Preferred Stock |
|
|
Series
AA Preferred Stock |
|
|
Common
Stock |
|
|
Stock |
|
|
Additional
Paid-In |
|
|
Accumulated |
|
|
Total
Stockholders’ |
|
|
|
Shares |
|
|
Amount |
|
|
Shares |
|
|
Amount |
|
|
Shares |
|
|
Amount |
|
|
Shares |
|
|
Amount |
|
|
Shares |
|
|
Amount |
|
|
Shares |
|
|
Amount |
|
|
Shares |
|
|
Amount |
|
|
Shares |
|
|
Amount |
|
|
Warrants |
|
|
Capital |
|
|
Deficit |
|
|
Deficit |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|